Company Analysis

Soligenix, Inc. (SNGX)

Nasdaq: SNGX · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 1995
Grade3.7
◀ Past 1.7● Present 4.1▶ Future 4.6
2 est.

Who runs Soligenix, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Schaber Christopher J
CHAIRMAN, CEO AND PRESIDENT. First filing Sep 2006, latest Oct 13, 2026, 9 filings in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
14 people on the record since 2006
Officerssales are open-market, Oct 13, 2025 to Oct 13, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Schaber Christopher JCHAIRMAN, CEO AND PRESIDENTSep 2006Oct 13, 2026none
Guarino Jonathan L.CFOSep 2019Oct 13, 2026none
Donini OreolaCSODec 2014Oct 13, 2026none
Straube RichardCMO (Consulting)Jan 2014Dec 12, 2025none
Directorssales are open-market, Oct 13, 2025 to Oct 13, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lapointe Anthony GreggdirectorMar 2009Oct 13, 2026none
Parks Diane L.directorJul 2019Oct 13, 2026none
Rubin Robert J.directorOct 2009Oct 13, 2026none
Zeldis Jerome BdirectorJun 2011Oct 13, 2026none
Earlier names on the record15, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SNGX · research, not advice